K. Alagiri et al. / Tetrahedron Letters 53 (2012) 1456–1459
1459
Commun. 2009, 2371–2372; (d) Murahashi, S.-I.; Komiya, N.; Terai, H. Angew.
Chem. Int. Ed. 2005, 44, 6931–6933; (e) Han, W.; Ofial, A. R. Chem. Commun.
2009, 5024–5026; (f) Li, Z.; Li, C.-J. Eur. J. Org. Chem. 2005, 3173–3176; (g)
Murahashi, S.-I.; Komiya, N.; Terai, H.; Nakae, T. J. Am. Chem. Soc. 2003, 125,
15312–15313; (h) Shu, X.-Z.; Xia, X.-F.; Yang, Y.-F.; Ji, K.-G.; Liu, X.-Y.; Liang, Y.-
M. J. Org. Chem. 2009, 74, 7464–7469; (i) Verma, S.; Jain, S. L.; Sain, B. Chem. Cat.
Chem. 2011, 3, 1329–1332.
H P(OR)2
O
Ph
N
O
O
Mo
O
H
I
P(OR)2
OH
3. Indolation by CDC (a) Li, Z.; Li, C.-J. J. Am. Chem. Soc. 2005, 127, 6968–6969; (b)
Liu, P.; Zhou, C.-Y.; Xiang, S.; Che, C.-M. Chem. Commun. 2010, 46, 2739–2741;
(c) Ghobrial, M.; Harhammer, K.; Mihovilovic, M. D.; Schnurch, M. Chem.
Commun. 2010, 46, 8836–8838.
4. Mannich like reaction by CDC (a) Sud, A.; Sureshkumar, D.; Klussmann, M.
Chem. Commun. 2009, 3169–3171; (b) Shen, Y.; Li, M.; Wang, S.; Zhan, T.; Tan,
Z.; Guo, C.-C. Chem. Commun. 2009, 953–955; (c) Yang, F.; Li, J.; Xie, J.; Huang,
Z.-Z. Org. Lett. 2010, 12, 5214–5217.
5. Aza-Henry reaction by CDC (a) Li, Z.; Li, C.-J. J. Am. Chem. Soc. 2005, 127, 3672–
3673; (b) Condie, A. G.; Gonzalez-Gomez, J. C.; Stephenson, C. R. J. J. Am. Chem.
Soc. 2010, 132, 1464–1465; (c) Basle, O.; Li, C.-J. Green Chem. 2007, 9, 1047–
1050; (d) Tsang, A. S.-K.; Todd, M. H. Tetrahedron Lett. 2009, 50, 1199–1202.
6. Zhao, L.; Li, C.-J. Angew. Chem., Int. Ed. 2008, 47, 7075–7078.
N
N
N
Ph
O
Ph
Ph
II
1a
+
O
Mo O
O
P(OR)2
O
+
OH
Mo
O
H2O
O2
Scheme 1. Plausible mechanism for the
a-phosphonation of N-aryl
tetrahydroisoquinolines.
7. Edmundson, S. In The Chemistry of Organophosphorus Compounds; Hartley, F. R.,
Ed.; John Wiley & Sons: New York, 1996; p 147. Vol. 4.
8. Atherton, F. R.; Hassall, C. H.; Lambert, R. W. J. Med. Chem. 1986, 29, 29–40.
9. Beers, S. A.; Schwender, C. F.; Loughney, D. A.; Malloy, E.; Demarest, K.; Jordan,
J. Bioorg. Med. Chem. 1996, 4, 1693–1701.
a
-aminophosphonates is the major strength of the present
method.
10. (a) Kabachnik, M. I.; Medved, T. Y. Dokl. Akad. Nauk SSSR 1952, 83, 689–692; (b)
Fields, E. K. J. Am. Chem. Soc. 1952, 74, 1528–1531.
Acknowledgments
11. (a) Pudovik, A. N. Dokl Akad. Nauk SSSR 1952, 83, 865–868; (b) Pudovik, A. N.;
Konovalova, I. V. Synthesis 1979, 81–96.
12. (a) Abell, J. P.; Yamamoto, H. J. Am. Chem. Soc. 2008, 130, 10521–10523; (b)
Cheng, X.; Goddard, R.; Buth, G.; List, B. Angew. Chem., Int. Ed. 2008, 47, 5079–
5081.
13. (a) Basle, O.; Li, C.-J. Chem. Commun. 2009, 4124–4126; (b) Rueping, M.; Zhu, S.;
Koenigs, R. M. Chem. Commun. 2011, 47, 8679–8681; (c) Hari, D. P.; Konig, B.
Org. Lett. 2011, 13, 3852–3855.
This work is supported by the Indian Institute of Science, CSIR,
New-Delhi (no. 01(2415)/10/EMR-II) and RL Fine Chem. We are
thankful to Dr. A. R. Ramesha and Prof. S. Chandrasekhar for
encouragement. One of the authors (KA) thanks the CSIR, New-Del-
hi for a senior research fellowship.
14. (a) Han, W.; Ofial, A. R. Chem. Commun. 2009, 6023–6025; (b) Han, W.; Mayer,
P.; Ofial, A. R. Adv. Synth. Catal. 2010, 352, 1667–1676.
Supplementary data
15. (a) Dams, M.; Vos, D. E. D.; Celen, S.; Jacobs, P. A. Angew. Chem., Int. Ed. 2003, 42,
3512–3515; Chen, X.; Hao, X.-S.; Goodhue, C. E.; Yu, J.-Q. J. Am. Chem. Soc. 2006,
128, 6790–6791; (c) Wendlandt, A. E.; Suess, A. M.; Stahl, S. S. Angew. Chem., Int.
Ed. 2011, 50, 11062–11087; (d) He, H.-F.; Wang, Z.-J.; Bao, W. Adv. Synth. Catal.
2010, 352, 2905–2912; (e) Chen, X.; Engle, K. M.; Wang, D.-H.; Yu, J.-Q. Angew.
Chem., Int. Ed. 2009, 48, 5094–5115; (f) King, A. E.; Huffman, L. M.; Casitas, A.;
Costas, M.; Ribas, X.; Stahl, S. S. J. Am. Chem. Soc. 2010, 132, 12068–12073.
16. (a) Alagiri, K.; Kumara, G. S. R.; Prabhu, K. R. Chem. Commun. 2011, 47, 11787–
11789; (b) Alagiri, K.; Prabhu, K. R. Org. Biomol. Chem. 2012, 67, 835–842.
17. (a) Maddani, M.; Prabhu, K. R. Tetrahedron Lett. 2008, 49, 4526–4530; (b)
Maddani, M.; Prabhu, K. R. Tetrahedron Lett. 2007, 48, 7151–7154.
Supplementary data (experimental procedure 1H and 13C NMR
spectral data for all new compounds) associated with this article
References and notes
1. CDC reviews (a) Li, C.-J. Acc. Chem. Res. 2009, 42, 335–344; (b) Scheuermann, C.
J. Chem. Asian J. 2010, 5, 436–451; (c) Murahashi, S.-I.; Zhang, D. Chem. Soc. Rev.
2008, 37, 1490–1501; (d) Li, Z.; Bohle, D. S.; Li, C.-J. Proc. Natl. Acad. Sci. U.S.A.
2006, 103, 8928–8933; (e) Yeung, C. S.; Dong, V. M. Chem. Rev. 2011, 111, 1215–
1292.
2. Cyanation by CDC (a) Murahashi, S.-I.; Nakae, T.; Terai, H.; Komiya, N. J. Am.
Chem. Soc. 2008, 130, 11005–11012; (b) Singhal, S.; Jain, S. L.; Sain, B. Adv.
Synth. Catal. 2010, 352, 1338–1344; (c) Singhal, S.; Jain, S. L.; Sain, B. Chem.
18. Typical experimental procedure: A mixture of 5 mol % of MoO3 (6.8 mg,
0.048 mmol), N-phenyl tetrahydroisoquinoline 1a (200 mg, 0.95 mmol) and
diethyl phosphite 2a (0.13 mL, 1.05 mmol) in MeOH (2 mL) was heated at 60 °C
under oxygen atmosphere (oxygen balloon) for 24 h. The solvent was removed
under vacuo, added water and extracted with DCM. The combined organic
layer was dried over Na2SO4, concentrated under reduced pressure, and
purified by column chromatography on silica gel using ethyl acetate/hexane
(1:4) to afford desired product 3a as pale yellow liquid (310 mg, 94%).